Verano Announces Promotion and Appointment of James Leventis as Chief Strategy and Compliance Officer
Verano Holdings (OTCQX: VRNOF) has promoted James Leventis to the position of Chief Strategy and Compliance Officer, effective July 1, 2025. Leventis, who joined Verano in 2019, will oversee the company's regulatory, licensing, compliance, and government affairs activities across its national operations.
A licensed attorney with nearly 15 years of experience in healthcare, pharmaceutical, consulting, and cannabis sectors, Leventis previously served as Executive Vice President of Legal, Regulatory and Government Affairs. He has been instrumental in Verano's transformation from a single-state operator to one of the largest publicly traded cannabis companies.
Leventis is actively involved in cannabis reform advocacy and serves on several industry boards including the United States Cannabis Roundtable and the American Trade Association of Cannabis and Hemp.
Verano Holdings (OTCQX: VRNOF) ha promosso James Leventis al ruolo di Chief Strategy and Compliance Officer, con effetto dal 1° luglio 2025. Leventis, entrato in Verano nel 2019, supervisionerà le attività regolatorie, di licenza, conformità e affari governativi dell'azienda a livello nazionale.
Avvocato abilitato con quasi 15 anni di esperienza nei settori sanitario, farmaceutico, consulenza e cannabis, Leventis ha ricoperto in precedenza la carica di Executive Vice President of Legal, Regulatory and Government Affairs. È stato fondamentale nella trasformazione di Verano da operatore locale a una delle più grandi aziende di cannabis quotate in borsa.
Leventis è attivamente coinvolto nella promozione della riforma della cannabis e fa parte di diversi consigli industriali, tra cui il United States Cannabis Roundtable e l'American Trade Association of Cannabis and Hemp.
Verano Holdings (OTCQX: VRNOF) ha promovido a James Leventis al cargo de Chief Strategy and Compliance Officer, con vigencia a partir del 1 de julio de 2025. Leventis, quien se unió a Verano en 2019, supervisará las actividades regulatorias, de licencias, cumplimiento y asuntos gubernamentales de la compañía a nivel nacional.
Abogado licenciado con casi 15 años de experiencia en los sectores de salud, farmacéutico, consultoría y cannabis, Leventis previamente se desempeñó como Vicepresidente Ejecutivo de Asuntos Legales, Regulatorios y Gubernamentales. Ha sido clave en la transformación de Verano de un operador estatal a una de las mayores empresas públicas de cannabis.
Leventis participa activamente en la defensa de la reforma del cannabis y forma parte de varias juntas industriales, incluyendo la United States Cannabis Roundtable y la American Trade Association of Cannabis and Hemp.
Verano Holdings (OTCQX: VRNOF)는 2025년 7월 1일부로 James Leventis를 Chief Strategy and Compliance Officer로 승진시켰습니다. 2019년 Verano에 합류한 Leventis는 회사의 전국 운영에 걸친 규제, 허가, 준수 및 정부 업무를 총괄할 예정입니다.
의료, 제약, 컨설팅, 대마초 분야에서 거의 15년의 경력을 가진 변호사인 Leventis는 이전에 법률, 규제 및 정부 업무 담당 수석 부사장으로 근무했습니다. 그는 Verano가 단일 주 운영자에서 가장 큰 상장 대마초 기업 중 하나로 성장하는 데 핵심적인 역할을 했습니다.
Leventis는 대마초 개혁 운동에 적극 참여하고 있으며, 미국 대마초 라운드테이블(United States Cannabis Roundtable)과 미국 대마초 및 햄프 무역협회(American Trade Association of Cannabis and Hemp)를 포함한 여러 산업 위원회에서 활동하고 있습니다.
Verano Holdings (OTCQX: VRNOF) a promu James Leventis au poste de Chief Strategy and Compliance Officer, à compter du 1er juillet 2025. Leventis, qui a rejoint Verano en 2019, supervisera les activités réglementaires, de licences, de conformité et les affaires gouvernementales de l'entreprise à l'échelle nationale.
Avocat agréé avec près de 15 ans d'expérience dans les secteurs de la santé, pharmaceutique, du conseil et du cannabis, Leventis a précédemment occupé le poste de vice-président exécutif des affaires juridiques, réglementaires et gouvernementales. Il a joué un rôle clé dans la transformation de Verano, passant d'un opérateur d'un seul État à l'une des plus grandes entreprises publiques de cannabis cotées en bourse.
Leventis est activement engagé dans la défense de la réforme du cannabis et siège à plusieurs conseils d'industrie, notamment le United States Cannabis Roundtable et l'American Trade Association of Cannabis and Hemp.
Verano Holdings (OTCQX: VRNOF) hat James Leventis zum Chief Strategy and Compliance Officer befördert, wirksam ab dem 1. Juli 2025. Leventis, der 2019 zu Verano kam, wird die regulatorischen, lizenzrechtlichen, Compliance- und Regierungsangelegenheiten des Unternehmens auf nationaler Ebene überwachen.
Als zugelassener Anwalt mit fast 15 Jahren Erfahrung in den Bereichen Gesundheitswesen, Pharmazie, Beratung und Cannabis war Leventis zuvor Executive Vice President für Recht, Regulierung und Regierungsangelegenheiten. Er spielte eine entscheidende Rolle bei Veranos Wandel von einem Einzelstaat-Betreiber zu einem der größten börsennotierten Cannabisunternehmen.
Leventis engagiert sich aktiv für Cannabisreformen und ist Mitglied mehrerer Branchenvorstände, darunter der United States Cannabis Roundtable und der American Trade Association of Cannabis and Hemp.
- Promotion strengthens executive leadership with experienced cannabis industry veteran
- Appointee brings diverse expertise across regulatory, compliance, M&A, and licensing
- Strong industry connections through leadership roles in major cannabis organizations
- None.
CHICAGO, July 15, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the promotion and appointment of James Leventis as the Company’s Chief Strategy and Compliance Officer, effective as of July 1, 2025.
As the newest member of Verano’s executive leadership team, Leventis will provide strategic leadership over the Company’s robust regulatory, licensing, compliance and government affairs activities across its expanding national footprint. Since joining the Company in 2019, he has played a critical role driving Verano’s growth from a single-state operator to one of the industry’s largest publicly traded companies. A seasoned cannabis executive and licensed attorney, Leventis most recently served as Executive Vice President of Legal, Regulatory and Government Affairs for the Company, and his nearly 15-year career spans a variety of disciplines including regulatory, compliance, M&A and licensing in the healthcare, pharmaceutical, consulting and cannabis sectors.
Leventis also plays a pivotal external role advocating for cannabis reform at the state and federal levels. Throughout his tenure, he has served as a founding member and executive officer on a number of boards, trade associations and political action committees, including the United States Cannabis Roundtable, the American Rights and Reform PAC, the American Trade Association of Cannabis and Hemp, and more.
“Given his extensive experience, industry knowledge and advocacy, I am thrilled to announce James’s promotion to Chief Strategy and Compliance Officer, and am confident that his unique skill sets and expertise will further strengthen our executive leadership team,” said George Archos, Verano founder and Chief Executive Officer. “As we navigate the dynamic cannabis sector, I believe Verano, and the industry at large, will benefit from James’s ongoing leadership and influence supporting important initiatives and legislative advancements, and we look forward to his contributions for years to come.”
About Verano
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano provides a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf™ and MÜV™ dispensary banners, including Cabbage Club™, an innovative annual membership program offering exclusive benefits for cannabis consumers. Verano produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano™, (the) Essence™, MÜV™, Savvy™, BITS™, Encore™, and Avexia™. Verano’s active operations span 13 U.S. states, comprised of 15 production facilities with over 1.1 million square feet of cultivation capacity. Learn more at Verano.com.
Contacts:
Media
Verano
Grace Bondy
Director, Communications
Grace.Bondy@verano.com
Investors
InvestorRelations@verano.com
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2024 and any subsequent quarterly reports on Form 10-Q, in each case, filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.
###
